Skip to main content
. 2005 Mar;91(3):290–298. doi: 10.1136/hrt.2003.031237

Table 3.

 Comparison of in-hospital pharmacological treatments for UK, European, and multinational groups of patients by baseline condition

ST elevation MI p Value Non-ST elevation MI p Value Unstable angina p Value
UK (n = 390) Eur (n = 2729) MN (n = 3696) UK v Eur UK v MN UK (n = 376) Eur (n = 160)2 MN (n = 4111) UK v Eur UK v MN UK (n = 605) Eur (n = 2174) MN (n = 4457) UK v Eur UK v MN
Aspirin 96% 94% 95% 0.1021 0.4041 94% 91% 92% 0.0685 0.6897 92% 90% 92% 0.1300 0.8024
Thienopyridine 18% 48% 40% <0.0001 <0.0001 31% 44% 31% <0.0001 0.8125 25% 29% 25% 0.0416 0.8229
β Blocker 82% 79% 86% 0.1093 0.0532 78% 77% 83% 0.7849 0.0036 73% 72% 79% 0.6805 0.0003
Ca2+ Blocker 16% 12% 16% 0.0268 0.9880 40% 25% 29% 0.0268 <0.0001 52% 39% 35% <0.0001 <0.0001
GP IIb/IIIa 6% 31% 28% <0.0001 <0.0001 6% 25% 26% <0.0001 <0.0001 3% 7% 11% <0.0001 <0.0001
LMWH 35% 62% 29% <0.0001 0.0159 74% 83% 39% <0.0001 <0.0001 68% 68% 34% 0.4799 <0.0001
Unfractionated heparin 67% 58% 73% 0.0003 0.0223 34% 45% 66% 0.0003 <0.0001 26% 30% 56% 0.0526 <0.0001
ACEI 56% 68% 70% <0.0001 <0.0001 48% 59% 57% <0.0001 0.0060 35% 56% 51% <0.0001 <0.0001
Statin 73% 58% 43% <0.0001 <0.0001 67% 54% 45% <0.0001 <0.0001 61% 47% 45% <0.0001 <0.0001